John P. Perentesis, MD, FAAP
College of Medicine - UC
Dr. Perentesis' clinical research focuses on the development of molecularly targeted therapies for pediatric and adolescent cancer. His laboratory program focuses on complementary studies of leukemia biology and pharmacogenetics of childhood cancer therapy. The laboratory has developed novel recombinant anticancer drugs, and discovery of genes involved in cellular regulation. Dr. Perentesis is also committed to expansion of the zebrafish model system in oncology.